Canine Degenerative Myelopathy: Managing a Progressive Neurological Disease

Degenerative myelopathy (DM) is a progressive, incurable spinal cord disease affecting several breeds. Welfare management focuses on maximising quality of life through physiotherapy, mobility aids, and timely end-of-life decisions.

Key Facts

Degenerative myelopathy is caused by a mutation in the SOD1 gene and is inherited in an autosomal recessive pattern; affected breeds include German Shepherd Dogs, Pembroke Welsh Corgis, Boxers, and Rhodesian Ridgebacks
DM typically begins with hind limb weakness and ataxia in middle-aged to older dogs (7-14 years) and progresses over 6-18 months to complete paraplegia
The disease is not painful in its early stages — affected dogs often remain bright, alert, and interested in life even as mobility declines significantly
Genetic testing for the SOD1 mutation can identify carriers and affected dogs before clinical signs appear, enabling breeding decisions that reduce disease frequency
Physiotherapy and hydrotherapy can slow functional decline and maintain muscle mass and joint mobility — dogs receiving regular physiotherapy may maintain ambulation significantly longer
Wheeled carts (dog wheelchairs) allow paraplegic dogs to remain mobile and active after hind limb function is lost, maintaining quality of life for months or years
Disease progression eventually involves forelimb weakness and dysphagia (difficulty swallowing) — at this stage, quality of life declines severely and euthanasia is typically appropriate

Welfare Considerations

DM poses particular welfare challenges because the disease progresses slowly through stages of very different welfare implications. In early stages, when the dog is mobile but weak, welfare can be excellent with appropriate support. As the dog becomes paraplegic but remains pain-free, bright, and engaged, wheelchair use and dedicated nursing can maintain a good quality of life. The critical welfare decision point comes when forelimb function begins to decline — at this stage, the dog loses the ability to engage meaningfully with its environment, and the burdens of care (pressure sores, urinary and faecal management) increase substantially. Timely, compassionate euthanasia before severe suffering develops is a central part of welfare-conscious DM management.

What You Can Do

Screen breeding dogs for the SOD1 mutation and avoid breeding homozygous affected animals
Enrol in physiotherapy or hydrotherapy programmes early after DM diagnosis to maximise functional lifespan
Discuss mobility aid options with your vet, including wheeled carts that can maintain quality of life through paraplegia
Learn pressure sore prevention and bladder management techniques as your dog progresses to paraplegia
Join canine DM support communities for peer support and practical management guidance from experienced owners
Work with your vet to establish quality of life assessment criteria so end-of-life decisions are made proactively
Support research into DM through the Orthopedic Foundation for Animals (OFA) and veterinary neurology research centres